Discover 1,168 paid clinical trials in Cincinnati, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
With a focus on a variety of conditions such as lymphoma, cancer, neurological diseases, and sleep apnea, Cincinnati is home to a wide array of clinical studies. The city's leading medical centers are actively recruiting participants, offering paid research opportunities for healthy volunteers or trials for specific health conditions, providing access to innovative treatments and therapies.
Filter
2
Filter results
Results: 1,168
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
for
Rectal Cancer
Location: Cincinnati OH, West Chester OH, Franklin OH,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT06205485
Phase 3, Recruiting
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Location: Cincinnati OH, West Chester OH, Pittsburgh PA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06654037
Phase 1, Recruiting
A Phase 1b Study of Menin Inhibitor SNDX- 5613 in Combination With Daunorubicin and Cytarabine in Newly Diagnosed Patients With Acute Myeloid Leukemia and NPM1 Mutated/FLT3 Wildtype or MLL/KMT2A Rearranged or NUP98 Alterations Disease
for
Acute Myeloid Leukemia,
Location: Cincinnati OH, West Chester OH, Columbus OH, Chicago IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18 - 70+
Code: NCT05886049
Phase 1, Recruiting
Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-Predominant Hodgkin Lymphoma, NORM Trial
for
Nodular Lymphocyte Predominant B-Cell Lymphoma,
Location: Cincinnati OH, West Chester OH, Columbus OH,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05886036
Phase 2, Recruiting
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
for
High-Risk Non-Muscle-Invasive Bladder Cancer
Location: Cincinnati OH, Jeffersonville IN, Greenwood IN,
Sponsor: CG Oncology, Inc.
Sex: All
Age: 18+
Code: NCT06567743
Phase 2, Recruiting
Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors
for
Melanoma Stage IV, Solid Tumor
Location: Cincinnati OH, Nashville TN, Richmond VA, New York NY,
Sponsor: Georgiamune Inc
Sex: All
Age: 18+
Code: NCT06425926
Phase 1, Phase 2, Recruiting
Testing the Addition of an Anti-Cancer Drug, ZEN003694, to the Usual Chemotherapy Treatment (Capecitabine) for Metastatic or Unresectable Cancers
for
Metastatic Colorectal Carcinoma,
Location: Cincinnati OH, West Chester OH, Nashville TN,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT05803382
Phase 1, Recruiting
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
for
Non-small Cell Lung Cancer
Location: Cincinnati OH, Skokie IL, Madison WI, Hamilton, Toronto,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06345729
Phase 3, Recruiting
Treatment With Amivantamab and Hyaluronidase or Cetuximab for Advanced Skin Cancer in People With a Weakened Immune System
for
Locally Recurrent Skin Squamous Cell Carcinoma,
Location: Cincinnati OH, West Chester OH, Danville IL, Mattoon IL,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07042295
Phase 2, Recruiting
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for
Angioimmunoblastic T-cell Lymphoma,
Location: Cincinnati OH, West Chester OH, Franklin OH,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT04803201
Phase 2, Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
for
Astrocytoma, IDH-Mutant, Grade 3
Location: Cincinnati OH, West Chester OH, Louisville KY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 12+
Code: NCT07215910
Phase 3, Recruiting
Family Communications After Genetic Testing
for
Colon Adenocarcinoma, Colorectal Adenocarcinoma,
Location: Cincinnati OH, West Chester OH, Franklin OH,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT07143487
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
for
B Acute Lymphoblastic Leukemia
Location: Cincinnati OH, West Chester OH, Lexington KY,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18 - 39
Code: NCT03150693
Phase 3, Recruiting
A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers
for
Colorectal Cancer, Gastric Adenocarcinoma,
Location: Cincinnati OH, Boston MA, Tampa FL, Salt Lake City UT,